Companies / Distalmotion

Medical device company profile

Distalmotion

Swiss medical device company developing and commercializing DEXTER robotic systems for minimally invasive soft-tissue surgery.

Medical Device ManufacturerSurgery & Procedural CareSurgical Instruments

Headquarters🇨🇭Epalinges, Vaud, Switzerland

Founded2012

Commercial statusCommercially availableDEXTER is commercially available in the United States and Europe.

Employees201–500 ^[5]LinkedIn company-size range · Checked 2026-11-02

Estimated revenueNot confirmed

Disclosed funding$150 million ^[6]Closed Series G led by Revival Healthcare Capital; distinct from the up-to-$70m secured loan facility announced October2026.

Official websitewww.distalmotion.com ↗

Company overview

Distalmotion is a Swiss surgical robotics company founded in 2012 and based in Epalinges, Vaud. Its DEXTER platform is designed for minimally invasive soft-tissue procedures in hospitals and ambulatory surgery centers.

DEXTER combines a surgeon console with mobile robotic patient carts. It is designed to work with existing operating-room visualization and other surgical equipment, supporting flexible use of robotic and laparoscopic techniques.

The system is commercially available in the United States and Europe. Its U.S. regulatory history includes an initial De Novo authorization and subsequent 510(k) clearances expanding its procedural scope.

^{[1][2][3][5][6][8]}

Leadership

6 people

Greg RocheChief Executive Officer ^[4][16]

Tony CollinsChief Financial Officer ^[4][17]

Sarah MooreChief Marketing Officer ^[4][18]

Sean McGrathChief People Officer ^[4][19]

Lionel FlactionChief Technology Officer ^[4][20]

Chas McKhannExecutive Chairman ^[4][21]

Products & regulatory status How does MedTechIndex get this information?

Summary

DEXTER received FDA De Novo authorization in October 2024, followed by four documented 510(k) clearances through August 2026. ^{[8][9][10][11][12]}

Regulatory snapshot How to read this snapshot

U.S. FDA

4+
510(k) clearances: 1+
De Novo grants: —
PMA approvals: —
Recall events

Latest recorded source review: 2026-11-02.

Scope: selected product families.

Commercial portfolio snapshot

Documented commercial product families.

Two DEXTER robotic patient carts with instrument arms — Image: Distalmotion

Surgical robotic system

DEXTER Robotic Surgery System ↗

Robotic platform for minimally invasive soft-tissue surgery, with a surgeon console, independently positioned patient carts and articulated instruments. U.S. authorizations cover specified general-surgery and gynecologic procedures. ^{[3][8][9][10][11][12]}

Commercially available in the U.S. and Europe